Key Square Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Gold Miners ETF
GDX
|
+$53.9M |
| 2 |
Merck
MRK
|
+$42.3M |
| 3 |
Gilead Sciences
GILD
|
+$41.4M |
| 4 |
Amgen
AMGN
|
+$41.1M |
| 5 |
Bausch Health
BHC
|
+$11.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$33.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 58.07% |
| 2 | Healthcare | 22.21% |
| 3 | Materials | 9.12% |
| 4 | Consumer Discretionary | 0.97% |
| 5 | Technology | 0.73% |
Similar funds
Key Square Capital Management's Q2 2017 Portfolio in Review
As of Q2 2017, Key Square Capital Management held 18 positions worth $671M, up 49% from $451M the previous quarter. Its ten largest holdings account for 98% of the portfolio.
Key Square Capital Management deployed $197M of net new capital in Q2 2017, opening 14 new positions and adding to 3 existing holdings. Its largest new stake was VanEck Gold Miners ETF: 2,371,000 shares worth $52.4M.
By sector, the portfolio is most concentrated in Financials at 58% of assets, down from 80% a quarter earlier, followed by Healthcare and Materials.
On the sell side, the most notable exit was Alibaba, an estimated $33.3M sold.
- Key Square Capital Management's largest Q2 2017 buy was VanEck Gold Miners ETF: 2,371,000 shares worth $52.4M.
- Key Square Capital Management added most to Bank of America in Q2 2017, an estimated $11.1M increase.
- Key Square Capital Management fully exited Alibaba in Q2 2017, selling an estimated $33.3M.
- Key Square Capital Management's ten largest holdings make up 98% of its $671M portfolio in Q2 2017.
- Key Square Capital Management opened 14 new positions and closed 1 in Q2 2017.
- Key Square Capital Management's portfolio value rose 49% quarter-over-quarter to $671M.
Based on Key Square Capital Management's 13F filing for Q2 2017, filed 9 Aug 2017.